This 2016 review examines the clinical characteristics, treatment strategies, and outcomes associated with metaplastic breast cancer (MBC), a rare and aggressive subtype of breast cancer. MBC is characterized by its resistance to conventional systemic therapies, including chemotherapy and hormonal therapy, contributing to its poor prognosis. The review discusses the unique
